We use cookies to customise content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. For further information, please read our cookie policy.
Information for healthcare professionals
ATLAS Study: Y-stenting subset
Treat bifurcations with confidence
The ATLAS Y-stenting subset is the largest single study to date, prospectively evaluated studying Y-stenting treatments of bifurcation aneurysms.
The results are in
Although Y-stenting is typically linked to higher rates of ischemic complications, results from the ATLAS IDE study show an incredible low complication rate of 3.3%.
Primary effectiveness endpoint
Primary safety endpoint
Results are based on retrospective subset analysis of a single-arm trial
Source: Jadhav AP, Desai SM, Jovin TG et al. Y-Stent–Assisted Coiling of Wide-Necked Intracranial Aneurysms With the Neuroform Atlas Stent System.
Stroke Vasc Interv Neurol. 2022;0:e000437
This information is intended solely for the use of healthcare professionals.
A physician must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that physicians be trained in the use of any particular product before using it in a procedure. The information presented is intended to demonstrate the breadth of Stryker product offerings. A physician must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.
Copyright © 2023 Stryker
AP-003949 V1.0